Search Results for keywords:"patient access"

Search Results: keywords:"patient access"

H. R. 10506 — To amend the Public Health Service Act to direct the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to award grants, contracts, or cooperative agreements for supporting new mobile cancer screening units to expand patient access to essential screening services in rural and underserved communities, and for other purposes.
💰
December 18, 2024
Status:Introduced in House
Congress:118
Words:1,096
H.R. 10506, also known as the “Mobile Cancer Screening Act,” aims to amend the Public Health Service Act to help more people in rural and underserved areas get screened for cancer. The bill directs the Secretary of Health and Human Services to provide grants, contracts, or...
Simple Explanation
The Mobile Cancer Screening Act wants to help more people in faraway towns see doctors who can check for cancer by setting up special vans that drive to them. It plans to give money to hospitals to do this and make sure they work with others to pay for it together.
H. R. 7383 — To amend the Federal Food, Drug, and Cosmetic Act to set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions.
February 15, 2024
Status:Introduced in House
Congress:118
Words:542
H. R. 7383, also known as the "Retaining Access and Restoring Exclusivity Act" or the "RARE Act," proposes changes to the Federal Food, Drug, and Cosmetic Act to limit the exclusive approval or licensure of drugs designated for treating rare diseases or conditions. The bill...
Simple Explanation
The bill wants to change the rules for special medicines made for rare diseases, so they can only be used for the specific health problem they were approved for, not the whole disease. It wants these changes to count for all these special medicines, no matter when they were first allowed to be used.
H. R. 7174 — To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
January 31, 2024
Status:Introduced in House
Congress:118
Words:261
H. R. 7174 proposes an amendment to the Social Security Act to make the negotiation period the same for small-molecule and biologic drug candidates under the Drug Price Negotiation Program. Specifically, the bill changes the current negotiation period from 7 years to 11...
Simple Explanation
H. R. 7174 is a bill that wants to change how long it takes to talk about and decide prices for new medicines, making it the same amount of time for all types of medicines. It suggests that instead of taking 7 years, this process should take 11 years.
H. R. 7442 — To direct the Comptroller General of the United States to conduct a study to assess the feasibility and financial effects of expanding coverage under the Medicare program to items and services furnished in the Philippines.
February 23, 2024
Status:Introduced in House
Congress:118
Words:420
H. R. 7442, also known as the “Philippine Medicare Portability Study Act,” directs the Comptroller General of the United States to conduct a study on expanding Medicare coverage to include healthcare services provided in the Philippines. The study will evaluate the...
Simple Explanation
H. R. 7442 is a plan to see if people with Medicare in the U.S. could get medical care in the Philippines, checking if it can save money and work well. They want to know what needs to change to make this happen and will tell Congress what they find out in six months.

Showing 1 to 4 of 4 results